WallStSmart

Enhabit Inc. (EHAB)vsHCA Healthcare, Inc. (HCA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 7073% more annual revenue ($76.39B vs $1.06B). HCA leads profitability with a 8.9% profit margin vs -0.3%. HCA earns a higher WallStSmart Score of 63/100 (C+).

EHAB

Hold

39

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 5.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

HCA

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 5/9Altman Z: 1.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EHAB.

HCASignificantly Overvalued (-85.5%)

Margin of Safety

-85.5%

Fair Value

$286.48

Current Price

$391.68

$105.20 premium

UndervaluedFair: $286.48Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EHAB1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

HCA4 strengths · Avg: 9.3/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-7.9110/10

Conservative balance sheet, low leverage

Market CapQuality
$86.89B9/10

Large-cap with strong market position

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

Areas to Watch

EHAB4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

EPS GrowthGrowth
2.9%4/10

2.9% earnings growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Market CapQuality
$706.91M3/10

Smaller company, higher risk/reward

HCA2 concerns · Avg: 4.0/10
Revenue GrowthGrowth
4.3%4/10

4.3% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : EHAB

The strongest argument for EHAB centers on Price/Book.

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.18 suggests the stock is reasonably priced for its growth.

Bear Case : EHAB

The primary concerns for EHAB are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : HCA

The primary concerns for HCA are Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

EHAB profiles as a turnaround stock while HCA is a value play — different risk/reward profiles.

HCA carries more volatility with a beta of 1.13 — expect wider price swings.

HCA is growing revenue faster at 4.3% — sustainability is the question.

HCA generates stronger free cash flow (895M), providing more financial flexibility.

Bottom Line

HCA scores higher overall (63/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Enhabit Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Enhabit, Inc. provides home health and hospice services in the United States.

Visit Website →

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?